Suppr超能文献

马来西亚大学医院结直肠癌患者的预后因素。

Prognostic factors in patients with colorectal cancer at Hospital Universiti Sains Malaysia.

机构信息

Unit of Biostatistics and Research Methodology, Universiti Sains Malaysia, 16150 Kubang Kerian Kelantan, Kelantan, Malaysia.

出版信息

Asian J Surg. 2010 Jul;33(3):127-33. doi: 10.1016/S1015-9584(10)60022-X.

Abstract

OBJECTIVE

To determine the 5-year survival rate and prognostic factors for survival in patients with colorectal cancer treated at the Surgical Unit, Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia.

METHODS

We retrospectively reviewed the records of 115 patients treated in HUSM from 1996 to 2005. Data of variables considered as prognostic factors were obtained from the records. Simple and multiple Cox proportional hazard regression using the stepwise method were used to model the prognostic factors for survival.

RESULTS

We found that the significant prognostic factors were liver metastases [adjusted hazard ratio (HR): 3.75; 95% confidence interval (CI): 1.95-7.22], Dukes C stage (adjusted HR: 4.65; 95% CI: 2.37-9.11), Dukes D stage (adjusted HR: 6.71; 95% CI: 2.92-15.48) and non-surgical treatment (adjusted HR: 3.75; 95% CI: 1.26-11.21).

CONCLUSION

Colorectal patients treated at HUSM with Dukes C staging, presence of liver metastases and received treatment with both chemotherapy and radiotherapy are at the greatest risk of death from colorectal cancer.

摘要

目的

确定在马来西亚大学科学医院(HUSM)外科病房接受治疗的结直肠癌患者的 5 年生存率和生存预后因素。

方法

我们回顾性分析了 1996 年至 2005 年在 HUSM 接受治疗的 115 例患者的记录。从记录中获取被认为是预后因素的变量数据。使用逐步法的简单和多 Cox 比例风险回归来对生存的预后因素进行建模。

结果

我们发现,显著的预后因素包括肝转移(调整后的风险比 [HR]:3.75;95%置信区间 [CI]:1.95-7.22)、 Dukes C 期(调整后的 HR:4.65;95% CI:2.37-9.11)、 Dukes D 期(调整后的 HR:6.71;95% CI:2.92-15.48)和非手术治疗(调整后的 HR:3.75;95% CI:1.26-11.21)。

结论

在 HUSM 接受治疗的结直肠癌患者中,Dukes C 分期、存在肝转移且接受化疗和放疗联合治疗的患者,死于结直肠癌的风险最高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验